Yozo Kawano

Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.

Fumihiro Tanaka, Yosuke Otake, Kazuhiro Yanagihara et al. · PubMed · 2001 · 275 citations

Medicine, Oncology, Pathology +12

Expression of angiopoietins and its clinical significance in non-small cell lung cancer.

Fumihiro Tanaka, Shinya Ishikawa, Kazuhiro Yanagihara et al. · PubMed · 2002 · 152 citations

Medicine, Oncology, Pathology +14

Expression of polysialic acid and STX, a human polysialyltransferase, is correlated with tumor progression in non-small cell lung cancer.

Fumihiro Tanaka, Yosuke Otake, Tatsuo Nakagawa et al. · PubMed · 2000 · 134 citations · Full text

Medicine, Molecular Biology, Oncology +9

Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer

Kazumasa Takenaka, Shinya Ishikawa, Yozo Kawano et al. · European Journal of Cancer · 2004 · 104 citations

Medicine, Cancer Biology, Oncology +12

Clinical Significance of p21 Expression in Non–Small-Cell Lung Cancer

Tsuyoshi Shoji, Fumihiro Tanaka, Tetsuya Takata et al. · Journal of Clinical Oncology · 2002 · 100 citations · Full text

Medicine, Molecular Biology, Oncology +17